Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.0006 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |